{"id":346,"date":"2013-03-14T06:14:00","date_gmt":"2013-03-14T06:14:00","guid":{"rendered":"\/?p=346"},"modified":"2013-03-25T19:35:59","modified_gmt":"2013-03-25T19:35:59","slug":"rxi-pharmaceuticals-corp-otcrxii-continues-with-steep-climb","status":"publish","type":"post","link":"\/articles\/rxi-pharmaceuticals-corp-otcrxii-continues-with-steep-climb\/","title":{"rendered":"RXi Pharmaceuticals, Corp. (OTC:RXII) Continues with Steep Climb"},"content":{"rendered":"<p> Biotechnologies continue to agitate the penny stock markets, and one of the more robust climbers in March is Rxi Pharmaceuticals, Corp. (OTC:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RXII\">RXII<\/a>), another explorer of novel therapies using RNA to cure disease by switching on and off selected human genes. <img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"http:\/\/www.hotstocked.com\/articles-img\/small\/RXII0314.png\" border=\"0\" alt=\"RXII0314.png\" title=\"RXII0314.png\" width=\"400\" height=\"178\" \/> <\/p>\n<p>The company currently needs to bear the costs of a long development process of a cutting-edge scientific application:&nbsp;<img loading=\"lazy\" decoding=\"async\" style=\"float: right;\" src=\"http:\/\/www.hotstocked.com\/articles-img\/small\/TTNP0314.png\" border=\"0\" alt=\"TTNP0314.png\" title=\"TTNP0314.png\" width=\"350\" height=\"156\" \/><\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li>$6.2 million cash <\/li>\n<\/ul>\n<ul>\n<li>$6.7 million total assets <\/li>\n<\/ul>\n<ul>\n<li>$1.4 million current liabilities <\/li>\n<\/ul>\n<ul>\n<li>$57,000 revenue from grants <\/li>\n<\/ul>\n<ul>\n<li>$1.6 million operating loss <\/li>\n<\/ul>\n<p>The latest pickup for <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RXII\">RXII<\/a> came from Todayspickis.com, as well as Tuesday&#8217;s press release about an upcoming presentation to an industry conference. This marked the last few days with robust volumes and a nearly 50% rise, from 20 to almost 30 cents per share.<\/p>\n<p><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RXII\">RXII<\/a> is a former NASDAQ company, pushed into OTC territory by the long wait for a marker breakthrough. As such, it was briefly mentioned in a promotional campaign back in 2010 and since then has relied more on press releases.<\/p>\n<p>The RNA therapies are a great potential area of new therapies and the credibility has carried over this stock in previous difficult periods. Now at all-time highs, <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RXII\">RXII<\/a> has traded between 5 and 30 cents, never sliding down to sub-penny prices. As such, <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RXII\">RXII<\/a> has the potential of a longer-term bet, although corrections of 50% are not a rare occurrence with this ticker.<\/p>\n<p>A close counterpart in business model and stock movement, Titan Pharmaceuticals Inc. (OTC:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=TTNP\">TTNP<\/a>) is having a good time in 2013. The stock added almost a dollar to its price, getting close to $2.50, and now is steady a little below $2. Titan has already well-established revenue streams from patented therapies and is giving hope for more drugs in the pipeline. <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=RXII\">RXII<\/a> is still quite far from this stage in its development.<\/p>\n<p>The biotech industry has had many surprises these days, mixing companies with great potential and a track record with offers of underpriced tickers that go up only through a paid promotion and go on to lose most of their value in a few days. It is best to look closer at the company&#8217;s records and independently where to place your investment.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/email.thestockmarketwatch.com\/wf\/open?upn=vzZzBY9Y6niCD8OCkromjDCcSvKMEpqS40G2OupyPS6wy8KbBYGnlzVd3rvJlEpFSiSopX9p2dJQBCZcDxJjZWXJaO2JvIIvsEZBZe5M0DifjJCMBW2fdLOqOgvN-2FwMdgBFtM3BYvjvjs4OcXnINIkK8jxgPHA6JnJy6Bp1QKb2iKsf8y2DnnUhvYa9SVGhh\" alt=\"\" width=\"1\" height=\"1\" border=\"0\" style=\"height:1px !important;width:1px !important;border-width:0 !important;margin-top:0 !important;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !important;padding-top:0 !important;padding-bottom:0 !important;padding-right:0 !important;padding-left:0 !important;\"\/> <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotechnologies continue to agitate the penny stock markets, and one of the more robust climbers in March is Rxi Pharmaceuticals, Corp. (OTC:RXII), another explorer of novel therapies using RNA to cure disease by switching&#46;&#46;&#46;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[42,11],"class_list":["post-346","post","type-post","status-publish","format-standard","hentry","category-news","tag-rxii","tag-ttnp"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=346"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/346\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}